IRVINTA - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 2,299 | - | 3,200 | 9,500 | 22,900 | 21,936 | 16,700 | 86,442 |
| Profit before tax | -7,410 | -3,661 | -6,269 | 673 | 9,679 | 6,716 | 567 | 15,205 |
| Net profit | -7,410 | -3,661 | -6,269 | 673 | 9,123 | 6,365 | 539 | 14,502 |
| Equity | -9,885 | -13,546 | -19,815 | -19,142 | -10,019 | -3,654 | -3,115 | 11,387 |
| Liabilities | 73,003 | 75,771 | 74,540 | 72,341 | 63,789 | 63,796 | 63,523 | 69,631 |
| Non-current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3,061 |
| Current assets | 63,118 | 62,225 | 54,725 | 53,199 | 53,249 | 53,469 | 53,626 | 70,925 |
| Total assets | 63,118 | 62,225 | 54,725 | 53,199 | 53,249 | 53,469 | 53,626 | 73,986 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 1,754 | 1,500 | 2,185 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -5.2% | - | - | +196.9% | +141.1% | -4.2% | -23.9% | +417.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -11.7% | -5.9% | -11.5% | 1.3% | 17.1% | 11.9% | 1.0% | 19.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | - | - | - | 127.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -322.3% | - | -195.9% | 7.1% | 39.8% | 29.0% | 3.2% | 16.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -322.3% | - | -195.9% | 7.1% | 42.3% | 30.6% | 3.4% | 17.6% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - | - | - | 6.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 2,299 | - | 3,200 | 9,500 | 22,900 | 21,936 | 16,700 | 64,833 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
IRVINTA - Social security debts
The company had no debts to Sodra
IRVINTA - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2024-06-20 | 2025-01-14 | 0.04 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
IRVINTA, UAB is a private limited liability company (code 302762333) engaged in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €86.4K and net profit of €14.5K, with a profit margin of 16.8%. This followed a much weaker 2024, when revenue was €16.7K and net profit €539, after €21.9K of revenue and €6.4K of net profit in 2023. The latest year therefore shows a strong rebound in both turnover and earnings, with revenue up 417.6% year on year and 294.1% over two years. At the end of 2025, total assets were €74.0K, equity €11.4K and liabilities €69.6K. Short-term assets accounted for €70.9K, while long-term assets were €3.1K. The equity ratio stood at 15.4% and debt-to-equity at 6.11, indicating a leveraged balance sheet. Asset turnover was 1.17x. Based on the latest year, revenue per employee was €86.4K and profit per employee €14.5K.